Pharma sales are not business as usual. Launching therapies in areas like central nervous system metabolic, rare diseases, and oncology isn’t a one-size-fits-all approach anymore—it takes strategy, customization, and expertise that many internal teams just don’t have the bandwidth for.
On top of that, the industry has shifted away from the old “share-of-voice” model to account-based selling. Customer relationship teams need new skills that incorporate in-person and virtual engagement, and enthusiasm for technology like AI to enable them to make more effective and efficient decisions. Now, it’s about engaging more than prescribers: think entire care teams (from pharmacists to benefit/coordination staff to nurses) and navigating complex decision-making processes. For already stretched in-house commercial teams, it’s a lot to handle.
That’s where outsourced pharma sales teams come in. They’re a smart, flexible solution for filling critical gaps and meeting market demands. Whether it’s building expertise in a specific therapeutic area, expanding reach, or creating operational infrastructure, these teams bring the skills and speed needed to get results.
And let’s face it, the stakes couldn’t be higher. Fierce Pharma reports that the top ten drug launches expected in 2026 are projected to generate $46 billion annually by 2032. With products spanning oncology, autoimmune diseases, and neurology, these high-value launches require larger teams, specialized roles, and smart deployment strategies to succeed.
Here’s how outsourced pharma sales teams help manufacturers tackle these challenges, and how Amplity can help:
Let’s dive into how these teams work, the models driving success, and real-world examples of what happens when you get it right.
When it comes to outsourced pharma sales teams, one size doesn’t fit all. Different sales team models—including remote, field, hybrid, and blended—offer distinct advantages depending on the product lifecycle, therapeutic area, and market dynamics. Let’s explore how these models can unlock commercial success.
Remote sales teams (aka virtual sales teams) are ideal for engaging mid-level HCPs, office staff, and pharmacists who prefer virtual interactions. They’re cost-effective, scalable, and perfect for covering large geographic areas, filling coverage gaps, and even managing vacancies in your field team.
Remote sales teams are particularly effective during the pre-launch phase, where identifying high-value HCPs and building early relationships is critical. According to Amplity’s Ben Lee, a Sales Director for outsourced teams, this is especially true for rare diseases, where the pool of HCPs is highly specialized and limited. “Amplity’s deep expertise in rare disease commercialization has proven vital in engaging these niche specialists—including pediatric neurologists and oncologists—early in the pre-launch process.”
For example, Amplity deployed a remote team for a biopharma client launching a rare disease therapy. Within six months, the team identified key HCPs, educated care teams, and built detailed customer profiles. The result? 93 new patient starts within the first 12 months, setting the stage for the field team to focus on high-priority accounts.
Brian O’Donnell, President of Commercial at Amplity, supports this approach: “Deploying remote teams early—before field teams—ensures that targets are validated and customer profiles are built. This allows field reps to focus their efforts on the highest-impact opportunities at launch.”
Other use cases for outsourced remote teams can include white-space coverage, inbound call handling, reimbursement issue resolution, vacancy management, and other value-add operational needs.
Field sales teams excel at building trust and navigating in-person interactions with high-value accounts. As Charles Arbuckle, a National Sales Director for an Amplity client, explains: “Face-to-face interactions still remain a core strategy in customer engagement, especially with prescribers. Field teams help establish trust and navigate complex conversations that can drive product adoption.”
Field teams are also effective for revitalizing mature brands or maintaining market presence during loss of exclusivity. For example, Amplity revitalized a mature brand by replacing the client’s in-house team with a bold sales model. They paired junior reps, who brought fresh, agile ideas, with experienced reps, who leveraged their deep expertise and strong client relationships. This strategy delivered a 10:1 ROI and $1.7 million in savings.
Says O’Donnell, “Amplity field teams offer versatile support for a manufacturer’s sales strategy. Whether it’s driving a stand-alone product launch, deploying a strikeforce for an upcoming or micro launch, or augmenting existing client teams to provide the coverage and support necessary, we deliver.”
Hybrid reps combine the best of both worlds, seamlessly switching between virtual pitches and face-to-face interactions based on customer needs.
As Steve Griffith, a National Sales Director for one of Amplity’s clients, explains, “Hybrid teams are incredibly versatile. The same rep can spend several days in the field building relationships with key HCPs and then seamlessly shift to remote engagement to conduct follow-ups across large geographical areas or multiple rural territories. This is particularly beneficial for managing products with unique administration requirements or executing competitive, rapid-deployment market blitzes.”
Blended teams integrate a combination of field, remote, hybrid, and/or digital engagement for a cohesive commercial strategy. According to L.E.K. Consulting, this omnichannel model is becoming essential for competitive advantage and sustained revenue growth.
“Our blended engagement model optimizes the communication mix across personal and non-personal channels, ultimately delivering relevant, timely, and credible information to HCPs when and where they want it,” says Christina DiBiase, Chief Growth Officer at Amplity.
Case in point: Amplity successfully deployed a blended salesforce for a mid-sized biopharma company launching its first oncology drug in a crowded U.S. market. With the client having limited internal expertise, Amplity designed and executed a scalable, data-driven sales strategy.
The blended team included field reps targeting high-value oncologists and key opinion leaders, alongside remote reps engaging less accessible HCPs. Leveraging Amplity’s proprietary AI platform, AnswerY™, the team identified high-potential territories and customer segments, enabling the client to prioritize resources for maximum impact.
The results were extraordinary: a 21:1 ROI that far exceeded expectations. Amplity’s phased scaling approach ensured the client optimized resource allocation without overextending.
“Blended teams help organizations to expand their reach without sacrificing quality. By integrating field and remote teams, companies gain the flexibility to adapt to market needs while achieving cost efficiency,” says Griffith.
Choosing outsourced pharma sales teams isn’t just about deploying a team; it’s about deploying the right team at the right time. Amplity’s tailored solutions align with your goals and deliver:
“From recruiting to upskilling to designing incentive programs, we provide the support you need to build an infrastructure for sales excellence,” says DiBiase.
Adding outsourced pharma sales teams to your commercial roadmap isn’t just smart; it can be the difference between success and failure.
Contact us today to learn how we can partner to optimize your sales strategy.
